FDA inspection
Auro Peptides Limited: FDA inspection ending Feb 16, 2024
FDA inspection 1234188 · No Action Indicated (NAI) · Sangareddy
Key facts
| Inspection ID | 1234188 |
|---|---|
| Firm | Auro Peptides Limited |
| FEI number | 3010923869 |
| Address | 4th Floor, & 72 Survey No 71 |
| City | Sangareddy |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Feb 16, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data